Allergy and Immunology · Enfield, CT
NPI
1518189612
Since 2007
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9 Cranbrook Blvd
Enfield, CT, 06082
Phone (860) 253-5330
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
3,603 services
Medicare patients, 2024
129
Average age 70
Drug cost, 2024
$871K
1,470 prescriptions
Company payments, 2025
$2,646
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jigisha P Morosky was code 95004 (test - miscellaneous), 2,775 times for 60 patients. In total Jigisha P Morosky billed 3,603 services in 14 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 2,775 | 60 | $2.91 | $8,084 |
| 95117 Treatment - Miscellaneous | Office | 150 | 12 | $9.41 | $1,412 |
| 99203 Office E&M - New | Office | 34 | 34 | $81.86 | $2,783 |
| 99204 Office E&M - New | Office | 34 | 34 | $125.65 | $4,272 |
| 99213 Office E&M - Established | Office | 29 | 29 | $75.69 | $2,195 |
| 99214 Office E&M - Established | Office | 28 | 27 | $89.97 | $2,519 |
By year: 2022 $30K for 3,631 services; 2023 $32K for 3,750 services; 2024 $29K for 3,603 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jigisha P Morosky prescribed most often to Medicare patients was Montelukast Sodium, with 277 prescriptions and refills. In total Jigisha P Morosky wrote 1,470 Medicare prescriptions that cost $871K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 277 | 696 | 88 | $2,603 |
| Fluticasone Propionate Generic | 213 | 548 | 109 | $4,768 |
| Famotidine Generic | 202 | 507 | 80 | $4,874 |
| Azelastine Hcl Generic | 170 | 397 | 84 | $6,281 |
| Levocetirizine Dihydrochloride Generic | 124 | 336 | 46 | $2,287 |
| Ipratropium Bromide Generic | 95 | 165 | 47 | $3,097 |
| Xolair Omalizumab | 84 | 84 | Under 11 | $237K |
| Azithromycin Generic | 33 | 55 | Under 11 | $768 |
| Qnasl Beclomethasone Dipropionate | 24 | 42 | Under 11 | $12K |
| Mometasone Furoate Generic | 22 | 46 | 12 | $2,183 |
| Epinephrine Generic | 21 | 21 | 20 | $4,191 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 17 | 23 | Under 11 | $16K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 17 | 17 | Under 11 | $218 |
| Breo Ellipta Fluticasone/Vilanterol | 17 | 39 | Under 11 | $15K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 13 | 23 | Under 11 | $1,121 |
Brand drugs: - claims; generic drugs: 1,237 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jigisha P Morosky $2,646 ($2,646 in general payments such as food, travel and fees) from 19 companies. The largest payer was Genzyme Corporation with $476.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 17 | $476 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $409 |
| Regeneron Healthcare Solutions, Inc. REGN | 13 | $342 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $227 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $207 |
| Optinose US, Inc. | 14 | $192 |
| GlaxoSmithKline, LLC. GSK | 9 | $154 |
| Genentech USA, Inc. ROG.SW | 5 | $108 |
| CSL Behring CSL.AX | 4 | $101 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $84.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.